Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Arcus Biosciences, Inc.
Duke University
AstraZeneca
USWM, LLC (dba US WorldMeds)
Poseida Therapeutics, Inc.
AstraZeneca
Seagen Inc.
University of Washington
OHSU Knight Cancer Institute
Novartis
M.D. Anderson Cancer Center
City of Hope Medical Center
University Health Network, Toronto
NeoTX Therapeutics Ltd.
BicycleTx Limited
SystImmune Inc.
Memorial Sloan Kettering Cancer Center
TCR2 Therapeutics
TCR2 Therapeutics
Exelixis
Jonsson Comprehensive Cancer Center
Cancer Research UK
Toray Industries, Inc
University of Alabama at Birmingham
Compugen Ltd
National Cancer Institute (NCI)
Tempus AI
First Affiliated Hospital of Chongqing Medical University
University Hospital, Antwerp
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Agenus Inc.
Carisma Therapeutics Inc
NextCure, Inc.
University of Toronto
Revolution Medicines, Inc.
Shanghai PerHum Therapeutics Co., Ltd.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
ENB Therapeutics, Inc
Baltimore VA Medical Center
Comprehensive Support Project for Oncology Research
NGM Biopharmaceuticals, Inc